1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Summary Of Recipharm Group

BASIC INFORMATION

Company Name

Employee Strength

Total No. of Subsidiary

Key Management

Designation

No.of Business Area

No. of Certification

Manufacturing Location

No. of Competitor

Website URL

VIEW DETAILED ANALYSIS (Click the items for details)

Business Area

Products Portfolio

Buying Portfolio

Subsidiary and Affiliates

Manufacturing Locations

Certifications/ Accreditation

Competition/Peer

Financials

Patent Filed

Warning Letter By Authority

Pipeline Products

Recent News

REGULATORY INFO (ACTIVE INGREDIENTS FILING/REGISTRATION/MARKET AUTHORIZATION)

North America

Europe

Asia

REGULATORY INFO - (FINISHED DOSAGE FORMS(FDF) FILING/REGISTRATION/MARKET AUTHORIZATION)

North America

Europe

National Registered

Centralised

Decentralised

Others

Oceania

Africa

Asia

South America

Clinical Trial

Biosimilar